Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|January 22, 2019
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex VivoJohannes P W Heidbuechel, Christine E EngelandJournal of Hematology & Oncology|April 17, 2021
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapiesJohannes P W Heidbuechel, Christine E EngelandMethods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Mathematical Modeling of Oncolytic VirotherapyJohannes P W Heidbuechel, Daniel Abate-Daga, Christine E Engeland, et al.Plos Computational Biology|July 30, 2026
In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocolAdrianne L Jenner, Robyn P Araujo, Noa L Levi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid TumorsTobias Speck, Johannes P W Heidbuechel, Rūta Veinalde, et al.Viruses|August 24, 2017
Fighting Cancer with Mathematics and VirusesDaniel N Santiago, Johannes P W Heidbuechel, Wendy M Kandell, et al.Cells|September 9, 2022
Tetraspanin 8 Subfamily Members Regulate Substrate-Specificity of a Disintegrin and Metalloprotease 17Miryam Müller, Claire Saunders, Anke Senftleben, et al.Molecular Therapy. Oncology|February 3, 2026
A measles virus encoding a CD19/CD3 bispecific T cell engager shows enhanced preclinical anti-BCP-ALL efficacy without significant toxicitySabine Heinze, Giovanna L Stadler, Yonghui Zhang, et al.Viruses|February 27, 2020
Measles Vaccines Designed for Enhanced CD8+ T Cell ActivationElena Busch, Kristina D Kubon, Johanna K M Mayer, et al.Pageof 1